MNOV (MediciNova) Short Ratio


MNOV MediciNova Inc MNOV
32 GF Score
Price $1.42
! 2 Warning Signs
View Full Analysis

What is MediciNova Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MNOV
32GF Score
MediciNova Inc MNOV
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediciNova Business Description

Other Exchanges 4875:Japan
Address 4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
32GF Score

Get the complete analysis for MNOV

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.42
Price